Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3321
Selected: 0
NCT IDTitle
NCT03856515Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
NCT03106077Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT01436240Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
NCT00038623Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
NCT07053059Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
NCT04947254Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
NCT01998529Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
NCT02138929LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma
NCT04666727Role of Diet on the Microbiome of the Digestive System
NCT02169505Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)
NCT05761951Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
NCT03193970Measuring Surgical Recovery After Radical Cystectomy
NCT01585194Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
NCT00907192Self Reported Deviations From Opioid Analgesic Prescription
NCT07856719A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy
NCT00498316Cord Blood Expansion on Mesenchymal Stem Cells
NCT01709292Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
NCT01548144Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer
NCT00739063Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer
NCT07444619A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
NCT00501319Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery
NCT00525057Dalteparin in Preventing DVT in Participants With Cancer
NCT00806507Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients
NCT05761964Harmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Northeast Texas
NCT05203614Positive Activities for Asian American Cancer Patients and Caregivers
NCT04614155Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women
NCT04594187Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
NCT05114421Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
NCT00848289Genetic Susceptibility to Bladder Cancer
NCT01370278Clearance Of Mucus In Stents (COMIS)
NCT00063258Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer
NCT02269085Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma
NCT05929716An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphoma
NCT03612531Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
NCT00720837Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
NCT00778375Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
NCT00003239Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
NCT00501228Tissue Repair in Stem Cell Transplant Recipients
NCT00469144IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
NCT00675467Palliative Care and Symptom Management for the Pediatric Oncology Patient
NCT05317936Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax
NCT06049134Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
NCT00345709Elizabeth Registry for Low Grade Ovarian Cancer
NCT00629200Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
NCT02629809Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT03053999Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
NCT03830151Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
NCT06466395A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
NCT06420206Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
NCT03752138TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia